eteplirsen
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for eteplirsen, covering 2019-02-20 to 2023-08-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) [Phase 2]